11.47 USD
↘ 0.32 (2.71%)LIVE (AS OF 09:37 AM EDT)
MiNK Therapeutics, Inc. Common Stock
INKTNASDAQ • USD
Market: OPEN
MiNK Therapeutics, Inc. Common Stock (INKT) trades at $11.47 per share. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (81.0%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$11.49
High?$11.79
Low?$11.47
Prev. Close?$11.79
Volume?146
Avg. Volume?9.6K
VWAP?$11.61
Rel. Volume?0.02x
Bid / Ask
Bid?$9.54 × 100
Ask?$13.68 × 100
Spread?$4.14
Midpoint?$11.61
Valuation & Ratios
Market Cap?60.2M
Shares Out?5.1M
Float?2.0M
Float %?39.2%
P/E Ratio?N/A
P/B Ratio?-4.29
EPS?-$2.23
Dividend?0.00%
Ex-Dividend?N/A
RelatedFTFT
News
Profile
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
Themes
Employees
15
Market Cap
60.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-10-15
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Phone: 212-994-8250
NEW YORK, NY 10010
Phone: 212-994-8250
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?73
Piotroski F-Score?0/9Weak
Altman Z-Score?-26.04Distress
Confidence?46%Low
Short InterestHigh
Short % of Float?4.01%Low
Short Interest?78.3K
Days to Cover?9.0
Free Float2.0M
Avg Daily Volume8.7K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.23Adequate
Quick Ratio?1.23Adequate
Cash Ratio?1.16Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-4.29CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?81.0%STRONG▾
S&P97
ROA?-118.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-6830483
Enterprise Value?$51.4M
Fundamentals ratios updated end of day